Massimo S. Fiandaca
Papers
1
Total Citations
20
H-Index
1
About
Massimo S. Fiandaca is a leading figure in translational neuroscience, whose work centers on developing advanced gene therapies for neurodegenerative disorders, most notably Parkinson’s Disease (PD). His major contributions lie in pioneering vector-based intracerebral gene therapy approaches, which deliver therapeutic genes directly to the central nervous system to slow or reverse disease progression. In his highly cited 2020 review, Fiandaca synthesizes the scientific rationale and technological innovations behind these treatments, addressing critical challenges such as vector design, delivery methods, and safety. With over 20 citations, this work has become a foundational resource for researchers navigating the complexities of CNS gene therapy. Beyond this, Fiandaca’s research has advanced the clinical translation of these therapies, bridging preclinical breakthroughs with human trials. His efforts have helped establish a framework for treating not only PD but also other neurological conditions, positioning him as a key architect of next-generation neurotherapeutics. For students and researchers, Fiandaca’s work exemplifies the rigorous, interdisciplinary thinking required to turn genetic medicine into real-world hope for patients with devastating brain diseases.
Research Focus
Key Achievements
Top Papers
- 1